Form 4 for AGIO AGIOS PHARMACEUTICALS, INC.
Accepted 2024-02-27 00:00:00 ET · period of report 2024-02-23 · accession 0001439222-24-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-02-27 | 2024-02-23+ | AGIO | Schenkein David P | Dir | M - OptEx | $31.64 | +68.1K | 170.6K | +67% | +$2.16M |
| DM | 2024-02-27 | 2024-02-23+ | AGIO | Schenkein David P | Dir | S - Sale+OE | $33.09 | -68.1K | 122.9K | -36% | -$2.25M |
| DM | 2024-02-27 | 2024-02-23+ | AGIO | Schenkein David P | Dir | M - OptEx | $0.00 | -68.1K | 89.7K | -43% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2024-02-26 | M | A | 20,411 | $31.64 | 143,265 | D | — | — | |
| 2 | Common | Common stock | 2024-02-26 | S | D | 20,411 | $33.19 | 122,854 | D | — | — | (F2) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $33.00 to $33.59. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common stock | 2024-02-23 | M | A | 47,731 | $31.64 | 170,585 | D | — | — | |
| 4 | Common | Common stock | 2024-02-23 | S | D | 47,731 | $33.05 | 122,854 | D | — | — | (F1) The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $33.00 to $33.27. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock option (right to buy) | 2024-02-26 | M | D | 20,411 | $0.00 | 69,329 | D | $31.64 · — to 2024-03-04 | 20,411 Common stock | (F5) This option was originally granted on March 5, 2014 for the purchase of 148,770 shares of common stock. The shares underlying this option vested as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. |
| 6 | Derivative | Stock option (right to buy) | 2024-02-23 | M | D | 47,731 | $0.00 | 89,740 | D | $31.64 · — to 2024-03-04 | 47,731 Common stock | (F5) This option was originally granted on March 5, 2014 for the purchase of 148,770 shares of common stock. The shares underlying this option vested as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter. |